Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!
Mar 01, 2024
Individuals suffering from food allergies now have access to a medication that can potentially avert serious consequences. This medication, which has been available for twenty years, has received approval from the FDA. Xolair (omalizumab) by Roche and Novartis is the first food allergy treatment sanctioned to dimin...
Read More...
Oct 18, 2023
Allergies are on the rise globally, affecting millions of people and significantly impacting their quality of life. The ability to accurately diagnose and manage allergies is crucial for both patients and healthcare providers. With the rising prevalence of allergy, the demand for Allergy Diagnostics has increased m...
Read More...
May 09, 2022
Food allergies are becoming a global concern. According to the World Allergy Organization, "food allergy impacted around 2.5% of the general population, but prevalence figures ranged from 1% to 10%." The increasing incidence of food allergies is raising food safety and public health issues and it is estimated that ...
Read More...
Mar 23, 2022
Food Allergies is a major concern for a wide spectrum of populations globally. According to the World Allergy Organization, “food allergy affected approximately 2.5% of the general population, but the spread of prevalence data was wide, ranging from 1% to 10%.” According to the Centers for Disease Control and Preve...
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
Newsletter/Whitepaper